CLONING OF THE PSEUDOHYPOPARATHYROIDISM TYPE 1B GENE
Project Number3R01DK056178-01S1
Contact PI/Project LeaderLEVINE, MICHAEL ALAN
Awardee OrganizationJOHNS HOPKINS UNIVERSITY
Description
Abstract Text
Pseudohypoparathyroidism (PHP) type 1 is an autosomal dominant disorder characterized by biochemical hypoparathyroidism due to resistance of target tissues to parathyroid hormone (PTH). Two fundamentally different forms of PHP type 1 have been described. In PHP type 1a, mutations in the GNAS1 gene lead to reduced expression or activity of the alpha subunit of the G protein (Gs alpha) that couples heptahelical receptors for PTH and many other hormones to activation of adenylyl cyclase. Accordingly, widespread deficiency of Gs alpha is associated with resistance not only to PTH but also to other hormones that act by stimulating adenylyl cyclase. By contrast, Gs alpha is normal in PHP type 1b, and hormone resistance is limited to PTH target tissues. These observations had suggested that the defect in PHP type 1b was the type 1 PTH receptor, but molecular analysis of this gene has not revealed mutations. The goal of this project is to identify and characterize the gene for PHP type 1b. We have used linkage analysis to assign the locus for PHP type 1b (designated PHP1b) to 10q26. This region contains a candidate gene that encodes the type 5 G protein-coupled receptor kinase (GRK 5), a protein kinase that can phosphorylate and desensitize the type 1 PTH receptor. To determine the PHP1b gene, a positional cloning strategy will be used involving the following approaches: (1) Further refine the PHP1b locus first by haplotype analysis of three additional PHP type 1b families we have ascertained, and subsequently by further analysis of all families using additional polymorphic markers mapped to this region. (2) Screen publicly available YAC clones and assemble a linear contig spanning the locus, and increase the resolution of the physical map. (3) Identify coding sequences in this region by review of publicly available EST maps, screening cDNA libraries by GeneTrapper methodology, and by exon-trapping. (4) Characterize transcripts through evaluation of homology to other known genes, patterns of tissue-specific expression, and cross-species conservation. (5) Perform mutational analysis of genomic DNA samples from familial and sporadic cases. Once the PHP1b gene is identified, the long-range goal will be to characterize the function of the gene product, to examine genotype-phenotype correlations, and to understand its role in regulating expression or action of the PTH receptor in health and disease.
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
847
DUNS Number
001910777
UEI
FTMTDMBR29C7
Project Start Date
01-September-1999
Project End Date
31-August-2004
Budget Start Date
01-April-2000
Budget End Date
31-August-2000
Project Funding Information for 2000
Total Funding
$75,706
Direct Costs
$46,162
Indirect Costs
$29,544
Year
Funding IC
FY Total Cost by IC
2000
National Institute of Diabetes and Digestive and Kidney Diseases
$75,706
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 3R01DK056178-01S1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3R01DK056178-01S1
Patents
No Patents information available for 3R01DK056178-01S1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3R01DK056178-01S1
Clinical Studies
No Clinical Studies information available for 3R01DK056178-01S1
News and More
Related News Releases
No news release information available for 3R01DK056178-01S1
History
No Historical information available for 3R01DK056178-01S1
Similar Projects
No Similar Projects information available for 3R01DK056178-01S1